Eiso Hiyama, Surgeon (Ph.D., Medicine), is is a surgical oncologist and biologist for Pediatric Cancers. Professor Emeritus and Distinguished Professor at Hiroshima University. Primary research areas include clinical trials of novel anticancer therapies and management of pediatric and AYA (Adolescent and Young Adult) cancers. Former President of the Japanese Society of Pediatric Hematology and Oncology; former Chair of the Liver Tumor Committee and Co-Chair of the Germ Cell Tumor Committee of the Japanese Childhood Cancer Group (JCCG). He was as a Director of the JCCG, a special member of Japanese Clinical Society of Oncology, a Council Member of the Japanese Society for Regenerative Medicine, and a Council Member of the Japan Surgical Society. He is currently a Full Member of the American Society of Clinical Oncology (ASCO), and an International Member of the Children's Oncology Group (COG). He graduated from Hiroshima University School of Medicine and holds the following certifications: National Medical License (1982), Board-Certified Surgeon (1999), Board-Certified Pediatric Surgeon (2001), Board-Certified Clinical Geneticist (2003), and Board-Certified Cancer Therapy Specialist (2008). His areas of expertise are as follows: Pediatric oncology (solid tumors, hepatoblastoma, neuroblastom), Molecular and translational cancer biology, Clinical genetics oncology, Surgical oncology and image guided surgery, and Regenerative medicine.